Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
434.30    -0.90 (-0.21%)
Bid:
436.00
Ask:
436.10
Spread: 0.10 (0.023%)
Market Cap: £10.93b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Holding(s) in Company

2 Sep 2015 07:00

RNS Number : 7736X
Rentokil Initial PLC
02 September 2015
Β 

ο»Ώ

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Rentokil Initial plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

√

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Aviva plc & its subsidiaries

4. Full name of shareholder(s) Β (if different from 3.):iv

Registered Holder:

Β 

BNY Norwich Union Nominees Limited 7,427,748*

Chase (GA Group) Nominees Limited 81,792,340*

Chase Nominees Limited 1,396,648*

Available on Request 22,255*

*denotes direct interest

Β 

Chase Nominees Limited 4,273,572

Vidacos Nominees Limited 5,324,132

Β 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

28 August 2015

6. Date on which issuer notified:

01 September 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

5% to 4% Change at direct interest level

Β 

Β 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary SharesGB00B082RF11

103,725,559

103,725,559

100,236,695

90,638,991

9,597,704

4.97%

0.53%

Β 

Β 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

Β 

Β 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

Β 

% of voting rights xix, xx

Β 

Nominal

Delta

Β 

Β 

Β 

Β 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

100,236,695

5.50%

Β 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chains of controlled undertakings:-

Β 

Aviva Investors Global Services Limited:

Β· Aviva plc (Parent Company)

Β· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

Β· Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

Β· Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

Β 

Friends Provident International Limited:

Β· Aviva plc (Parent Company)

Β· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

Β· Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

Β· Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited)

Β· Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited)

Β· Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited)

Β· Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited)

Β· Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited)

Β 

Β 

Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

Figures are based on a total number of voting rights of 1,822,832,965

Β 

14. Contact name:

Daragh Fagan - Company Secretary, Rentokil Initial plc

Β 

15. Contact telephone number:

01276 607444

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLUAABRVVAKRAR
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.